急性脑出血患者的急性高血压反应:叙述性综述
该叙述性综述评估了急性脑出血中急性高血压反应的发生频率、对临床结局的影响、与继发性脑损伤的关系、血管自动调节及降压治疗安全性,并汇总随机临床试验与荟萃分析。急性高血压反应常见且与不良结局相关,但当前指南推荐的强化降压(<140 mm Hg)缺乏一致临床获益证据,可能对部分患者有益而对另一些有害。
要点
- 急性高血压反应在脑出血患者中常见且与不良临床结局相关。
- 指南推荐强化降压(<140 mm Hg),但两项随机临床试验未显示一致临床获益。
- 脑出血异质性高,一刀切降压策略可能不理想,需识别获益亚组。
核心结论
- 急性高血压反应常见且与不良结局相关,但是否为不良结局的原因或仅为严重度标志尚不明确。
- 脑出血为异质性疾病,一刀切血压治疗可能不理想,需进一步研究识别从积极降压中获益的亚组。
研究设计与样本
- 叙述性综述,检索文献评估急性高血压反应频率、临床结局后果、继发性脑损伤、血管自动调节与降压安全性、随机临床试验及荟萃分析。
主要发现
- 急性高血压反应在急性脑出血患者中常见,并与不良临床结局相关。
- 两项随机临床试验未能证明强化降压(<140 mm Hg)带来一致临床获益。
- 新数据提示强化降压可能对部分患者有益而对另一些患者有害。
关键数值与推荐
- 当前指南推荐脑出血患者强化降压治疗(<140 mm Hg)。
临床怎么用
- 脑出血患者应评估急性高血压反应,但强化降压需考虑异质性,避免一刀切策略。
- 未来应结合病因、超早期随机化及血肿扩大影像风险标志物识别降压获益亚组。
局限性
- 为叙述性综述,未提供系统检索策略或定量合并分析。
- 急性高血压反应与不良结局的因果关系尚不明确。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To review the role of the acute hypertensive response in patients with intracerebral hemorrhage, current treatment options, and areas for further research. METHODS: Review of the literature to assess 1) frequency of acute hypertensive response in intracerebral hemorrhage; 2) consequences of acute hypertensive response in clinical outcomes; 3) acute hypertensive response and secondary brain injury: hematoma expansion and perihematomal edema; 4) vascular autoregulation, safety data side effects of acute antihypertensive treatment; and 5) randomized clinical trials and meta-analyses. RESULTS: An acute hypertensive response is frequent in patients with acute intracerebral hemorrhage and is associated with poor clinical outcomes. However, it is not clear whether high blood pressure is a cause of poor clinical outcome or solely represents a marker of severity. Although current guidelines recommend intensive blood pressure treatment (<140 mm Hg) in patients with intracerebral hemorrhage, 2 randomized clinical trials have failed to demonstrate a consistent clinical benefit from this approach, and new data suggest that intensive blood pressure treatment could be beneficial for some patients but detrimental for others. CONCLUSIONS: Intracerebral hemorrhage is a heterogenous disease, thus, a one-fit-all approach for blood pressure treatment may be suboptimal. Further research should concentrate on finding subgroups of patients more likely to benefit from aggressive blood pressure lowering, considering intracerebral hemorrhage etiology, ultra-early randomization, and risk markers of hematoma expansion on brain imaging.
引用
- Hawkes MA, Rabinstein AA. Acute Hypertensive Response in Patients With Acute Intracerebral Hemorrhage: A Narrative Review. Neurology. 2021. PMID: 34031208. doi:10.1212/WNL.0000000000012276
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。